CTS Eventim has expanded its business operations in Israel through a joint venture with promoters Zappa Group.
Through the partnership, Zappa will gain access to the Berlin-based ticketing a live entertainment company’s range of eCommerce marketing tools and technologies, such as data analytics or the web shop for ticket sales.
Klaus-Peter Schulenberg, chief executive of Eventim, said: “We are pleased to join forces on Israel’s dynamic market with our partner Zappa, and to jointly develop and further exploit the potential there.
“Zappa’s paramount role in live entertainment and CTS Eventim’s expertise in technology and marketing are a perfect combination.”
Golan Einat, the owner of the Zappa Group, which is a key local promoter of live events, including a dozen popular festivals, and operates venues in Israel that seat up to 15,000, said: “Thanks to cutting-edge technology, professional capabilities and many years of experience, I have no doubt that this joint venture is primarily designed for the benefit of the ticket buyers who will enjoy the wide and varied content provided by CTS Eventim and the Zappa Group.”
By mid-February, more than 40 per cent of the Israeli population had already been vaccinated against COVID-19, which has shuttered the live events industry worldwide since March 2020. It is now expected that most of the population outside the occupied territories will be vaccinated by spring of this year.
Ami Feinstein, Eventim’s managing director in Israel, added: “We’ve been working on our partnership with Zappa for a long time. We are sure that the synergy in this venture will produce changes in the ticketing market in Israel, in the form of superb customer service and advanced and superior technology – just like nine years ago, when Eventim entered the Israeli market. So we are excited about returning to business activity in a post-Corona era.”
Earlier this month, Schulenberg told business magazine Wirtschaftswoche that he believes event organisers should play their part in promoting COVID-19 vaccinations by making immunisation status a requirement of entry to venues.
He said Eventim, which owns TicketOne, already has the scanning technology to check both the tickets and vaccination records of attendees.